This site is intended for health professionals only

Editor’s pick

CRT cuts cardiac death-rate
CRT cuts cardiac death-rate
US-Europe pioglitazone labelling differences clarified
US-Europe pioglitazone labelling differences clarified
Big changes loom for pharma
Big changes loom for pharma
Biobank project: public fears addressed
Biobank project: public fears addressed
Anidulafungin “not inferior to fluconazole”
Anidulafungin “not inferior to fluconazole”
Repligen gains in Erbitux dispute
Repligen gains in Erbitux dispute
Revolution ahead in RA treatment?
Revolution ahead in RA treatment?
Anastrazole switch holds cancer hope
Anastrazole switch holds cancer hope
Cigarettes “may affect irinotecan outcome”
Cigarettes “may affect irinotecan outcome”
Sensitivity and allergy software launched
Sensitivity and allergy software launched
Acomplia may face rough ride
Acomplia may face rough ride
Anti-TNF agents: no raised risk
Anti-TNF agents: no raised risk
1 … 259 260 261 262 263 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x